NM_004393.6:c.41C>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004393.6(DAG1):​c.41C>G​(p.Ser14Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.996 in 1,613,856 control chromosomes in the GnomAD database, including 800,027 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S14L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.98 ( 72546 hom., cov: 27)
Exomes 𝑓: 1.0 ( 727481 hom. )

Consequence

DAG1
NM_004393.6 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.73

Publications

36 publications found
Variant links:
Genes affected
DAG1 (HGNC:2666): (dystroglycan 1) This gene encodes dystroglycan, a central component of dystrophin-glycoprotein complex that links the extracellular matrix and the cytoskeleton in the skeletal muscle. The encoded preproprotein undergoes O- and N-glycosylation, and proteolytic processing to generate alpha and beta subunits. Certain mutations in this gene are known to cause distinct forms of muscular dystrophy. Alternative splicing results in multiple transcript variants, all encoding the same protein. [provided by RefSeq, Nov 2015]
DAG1 Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy type 2P
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Orphanet
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated asymptomatic elevation of creatine phosphokinase
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.2135001E-6).
BP6
Variant 3-49510575-C-G is Benign according to our data. Variant chr3-49510575-C-G is described in ClinVar as Benign. ClinVar VariationId is 226558.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DAG1NM_004393.6 linkc.41C>G p.Ser14Trp missense_variant Exon 2 of 3 ENST00000308775.7 NP_004384.5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DAG1ENST00000308775.7 linkc.41C>G p.Ser14Trp missense_variant Exon 2 of 3 1 NM_004393.6 ENSP00000312435.2

Frequencies

GnomAD3 genomes
AF:
0.976
AC:
148289
AN:
151908
Hom.:
72491
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.916
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.992
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
1.00
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
0.987
GnomAD2 exomes
AF:
0.994
AC:
249425
AN:
251000
AF XY:
0.995
show subpopulations
Gnomad AFR exome
AF:
0.914
Gnomad AMR exome
AF:
0.996
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
0.997
GnomAD4 exome
AF:
0.998
AC:
1458269
AN:
1461830
Hom.:
727481
Cov.:
78
AF XY:
0.998
AC XY:
725686
AN XY:
727212
show subpopulations
African (AFR)
AF:
0.914
AC:
30612
AN:
33480
American (AMR)
AF:
0.996
AC:
44524
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
26136
AN:
26136
East Asian (EAS)
AF:
1.00
AC:
39700
AN:
39700
South Asian (SAS)
AF:
1.00
AC:
86232
AN:
86256
European-Finnish (FIN)
AF:
1.00
AC:
53369
AN:
53370
Middle Eastern (MID)
AF:
0.998
AC:
5747
AN:
5758
European-Non Finnish (NFE)
AF:
1.00
AC:
1111864
AN:
1112010
Other (OTH)
AF:
0.995
AC:
60085
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
214
428
642
856
1070
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21668
43336
65004
86672
108340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.976
AC:
148403
AN:
152026
Hom.:
72546
Cov.:
27
AF XY:
0.976
AC XY:
72563
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.917
AC:
37956
AN:
41412
American (AMR)
AF:
0.992
AC:
15132
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3472
AN:
3472
East Asian (EAS)
AF:
0.999
AC:
5169
AN:
5172
South Asian (SAS)
AF:
1.00
AC:
4798
AN:
4800
European-Finnish (FIN)
AF:
1.00
AC:
10606
AN:
10606
Middle Eastern (MID)
AF:
1.00
AC:
294
AN:
294
European-Non Finnish (NFE)
AF:
1.00
AC:
67983
AN:
68002
Other (OTH)
AF:
0.987
AC:
2081
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
165
330
494
659
824
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.943
Hom.:
16724
Bravo
AF:
0.973
TwinsUK
AF:
1.00
AC:
3708
ALSPAC
AF:
1.00
AC:
3854
ESP6500AA
AF:
0.921
AC:
4059
ESP6500EA
AF:
1.00
AC:
8596
ExAC
AF:
0.992
AC:
120479
Asia WGS
AF:
0.995
AC:
3461
AN:
3478
EpiCase
AF:
1.00
EpiControl
AF:
0.999

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 26, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This is a RefSeq error. The reference base (c.41C) is the minor allele. This all ele (C) has been identified in 0.05% (4/8600) of European American chromosomes a nd 7.9% (347/4406) of African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs2131107). -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Autosomal recessive limb-girdle muscular dystrophy type 2P Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9;C4511963:Autosomal recessive limb-girdle muscular dystrophy type 2P Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
20
DANN
Benign
0.16
DEOGEN2
Benign
0.34
T;T;T;T;T;T;T;.;.;.;.;.;T;.
Eigen
Benign
-0.97
Eigen_PC
Benign
-0.71
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.090
T;T;.;.;.;.;.;T;T;T;T;T;T;.
MetaRNN
Benign
0.0000012
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-1.4
N;.;N;N;N;N;N;.;.;.;.;.;.;.
PhyloP100
1.7
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-0.090
N;N;N;N;N;N;N;N;N;N;N;N;N;D
REVEL
Benign
0.20
Sift
Benign
1.0
T;T;T;T;T;T;T;T;T;T;T;T;T;.
Sift4G
Benign
0.18
T;T;T;T;T;T;T;T;T;T;T;T;T;.
Polyphen
0.0
B;.;B;B;B;B;B;.;.;.;.;.;.;.
Vest4
0.10
MPC
0.37
ClinPred
0.0070
T
GERP RS
4.7
Varity_R
0.027
gMVP
0.42
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2131107; hg19: chr3-49548008; COSMIC: COSV107353611; COSMIC: COSV107353611; API